Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(1.13)
# 3,820
Out of 5,140 analysts
350
Total ratings
25%
Success rate
-10.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AUTL Autolus Therapeutics | Initiates: Buy | $9 | $1.67 | +438.92% | 1 | Feb 17, 2026 | |
| AGIO Agios Pharmaceuticals | Maintains: Buy | $62 → $65 | $29.25 | +122.22% | 5 | Feb 12, 2026 | |
| NVCR NovoCure | Maintains: Buy | $39 → $47 | $11.36 | +313.73% | 21 | Feb 12, 2026 | |
| ACLX Arcellx | Reiterates: Buy | $115 | $64.11 | +79.38% | 14 | Feb 4, 2026 | |
| RAPT RAPT Therapeutics | Downgrades: Neutral | $58 | $57.92 | +0.14% | 4 | Jan 20, 2026 | |
| VTYX Ventyx Biosciences | Downgrades: Neutral | $14 | $13.97 | +0.21% | 17 | Jan 8, 2026 | |
| VTVT vTv Therapeutics | Maintains: Buy | $36 → $47 | $34.30 | +37.03% | 3 | Dec 19, 2025 | |
| RCUS Arcus Biosciences | Maintains: Buy | $28 → $32 | $18.99 | +68.51% | 7 | Dec 12, 2025 | |
| OLMA Olema Pharmaceuticals | Maintains: Buy | $36 → $45 | $24.08 | +86.88% | 23 | Dec 11, 2025 | |
| ACRV Acrivon Therapeutics | Reiterates: Buy | $19 | $1.53 | +1,141.83% | 13 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $51 | $54.19 | -5.89% | 13 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $4.68 | +220.51% | 2 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $9 | $4.01 | +124.44% | 12 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $5 | $2.24 | +123.21% | 13 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.86 | +1,295.35% | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $60 | $29.53 | +103.18% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.34 | - | 14 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $3.06 | +651.63% | 20 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $40 | $3.92 | +920.41% | 15 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $35 | $11.37 | +207.83% | 14 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $0.54 | +1,377.38% | 25 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $9 | $3.57 | +152.10% | 2 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $20 | $1.32 | +1,415.15% | 10 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $14.05 | +156.15% | 9 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $560 → $280 | $9.69 | +2,789.58% | 17 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.65 | +201.89% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.64 | +1,036.36% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $2.33 | +672.53% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $183 | $3.22 | +5,571.12% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $4.21 | +731.35% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.88 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $0.50 | +6,565.32% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.61 | - | 1 | Apr 25, 2024 |
Autolus Therapeutics
Feb 17, 2026
Initiates: Buy
Price Target: $9
Current: $1.67
Upside: +438.92%
Agios Pharmaceuticals
Feb 12, 2026
Maintains: Buy
Price Target: $62 → $65
Current: $29.25
Upside: +122.22%
NovoCure
Feb 12, 2026
Maintains: Buy
Price Target: $39 → $47
Current: $11.36
Upside: +313.73%
Arcellx
Feb 4, 2026
Reiterates: Buy
Price Target: $115
Current: $64.11
Upside: +79.38%
RAPT Therapeutics
Jan 20, 2026
Downgrades: Neutral
Price Target: $58
Current: $57.92
Upside: +0.14%
Ventyx Biosciences
Jan 8, 2026
Downgrades: Neutral
Price Target: $14
Current: $13.97
Upside: +0.21%
vTv Therapeutics
Dec 19, 2025
Maintains: Buy
Price Target: $36 → $47
Current: $34.30
Upside: +37.03%
Arcus Biosciences
Dec 12, 2025
Maintains: Buy
Price Target: $28 → $32
Current: $18.99
Upside: +68.51%
Olema Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $36 → $45
Current: $24.08
Upside: +86.88%
Acrivon Therapeutics
Nov 25, 2025
Reiterates: Buy
Price Target: $19
Current: $1.53
Upside: +1,141.83%
Nov 24, 2025
Maintains: Buy
Price Target: $52 → $51
Current: $54.19
Upside: -5.89%
Nov 12, 2025
Maintains: Buy
Price Target: $12 → $15
Current: $4.68
Upside: +220.51%
Nov 7, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $4.01
Upside: +124.44%
Nov 6, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $2.24
Upside: +123.21%
Oct 14, 2025
Initiates: Buy
Price Target: $12
Current: $0.86
Upside: +1,295.35%
Oct 6, 2025
Assumes: Buy
Price Target: $60
Current: $29.53
Upside: +103.18%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.34
Upside: -
Sep 10, 2025
Reiterates: Buy
Price Target: $23
Current: $3.06
Upside: +651.63%
Aug 27, 2025
Maintains: Buy
Price Target: $32 → $40
Current: $3.92
Upside: +920.41%
Aug 15, 2025
Upgrades: Buy
Price Target: $35
Current: $11.37
Upside: +207.83%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $0.54
Upside: +1,377.38%
Jul 22, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $3.57
Upside: +152.10%
Jul 7, 2025
Maintains: Buy
Price Target: $40 → $20
Current: $1.32
Upside: +1,415.15%
Jul 1, 2025
Reiterates: Buy
Price Target: $36
Current: $14.05
Upside: +156.15%
Apr 16, 2025
Maintains: Buy
Price Target: $560 → $280
Current: $9.69
Upside: +2,789.58%
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $2.65
Upside: +201.89%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $2.64
Upside: +1,036.36%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $2.33
Upside: +672.53%
Mar 26, 2025
Reiterates: Buy
Price Target: $183
Current: $3.22
Upside: +5,571.12%
Mar 26, 2025
Reiterates: Buy
Price Target: $35
Current: $4.21
Upside: +731.35%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.88
Upside: -
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $0.50
Upside: +6,565.32%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $2.61
Upside: -